INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,727,427 | -25.4% | 550,580 | 0.0% | 0.00% | – |
| Q2 2023 | $4,999,266 | +42.9% | 550,580 | +1.6% | 0.00% | – |
| Q1 2023 | $3,499,014 | +1.9% | 541,643 | 0.0% | 0.00% | – |
| Q4 2022 | $3,434,016 | +2.3% | 541,643 | +0.0% | 0.00% | – |
| Q3 2022 | $3,357,000 | -31.4% | 541,398 | -2.2% | 0.00% | – |
| Q2 2022 | $4,894,000 | +5.0% | 553,638 | 0.0% | 0.00% | – |
| Q1 2022 | $4,661,000 | -10.6% | 553,638 | +8.3% | 0.00% | – |
| Q4 2021 | $5,212,000 | -40.2% | 511,029 | +13.8% | 0.00% | – |
| Q3 2021 | $8,718,000 | +30.9% | 448,911 | +18.4% | 0.00% | – |
| Q2 2021 | $6,661,000 | +79.0% | 379,168 | +21.1% | 0.00% | – |
| Q1 2021 | $3,721,000 | -14.6% | 313,220 | +23.8% | 0.00% | – |
| Q4 2020 | $4,356,000 | +104.4% | 252,931 | +22.4% | 0.00% | – |
| Q3 2020 | $2,131,000 | – | 206,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |